Literature DB >> 27343691

TRAP-positive osteoclast precursors mediate ROS/NO-dependent bactericidal activity via TLR4.

Kazuaki Nishimura1, Satoru Shindo2, Alexandru Movila3, Rayyan Kayal4, Albassam Abdullah5, Irma Josefina Savitri6, Atsushi Ikeda7, Tsuguno Yamaguchi8, Mohammed Howait9, Ayman Al-Dharrab10, Abdulghani Mira11, Xiaozhe Han12, Toshihisa Kawai13.   

Abstract

Osteoclastogenesis was induced by RANKL stimulation in mouse monocytes to examine the possible bactericidal function of osteoclast precursors (OCp) and mature osteoclasts (OCm) relative to their production of NO and ROS. Tartrate-resistant acid phosphatase (TRAP)-positive OCp, but few or no OCm, phagocytized and killed Escherichia coli in association with the production of reactive oxygen species (ROS) and nitric oxide (NO). Phagocytosis of E. coli and production of ROS and NO were significantly lower in TRAP+ OCp derived from Toll-like receptor (TLR)-4 KO mice than that derived from wild-type (WT) or TLR2-KO mice. Interestingly, after phagocytosis, TRAP+ OCp derived from wild-type and TLR2-KO mice did not differentiate into OCm, even with continuous exposure to RANKL. In contrast, E. coli-phagocytized TRAP+ OCp from TLR4-KO mice could differentiate into OCm. Importantly, neither NO nor ROS produced by TRAP+ OCp appeared to be engaged in phagocytosis-induced suppression of osteoclastogenesis. These results suggested that TLR4 signaling not only induces ROS and NO production to kill phagocytized bacteria, but also interrupts OCm differentiation. Thus, it can be concluded that TRAP+ OCp, but not OCm, can mediate bactericidal activity via phagocytosis accompanied by the production of ROS and NO via TLR4-associated reprograming toward phagocytic cell type.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteria; Nitric oxide; Osteoclast; Phagocytosis; RANKL; Reactive oxygen species; Tartrate-resistant acid phosphatase; Toll-like receptor

Mesh:

Substances:

Year:  2016        PMID: 27343691      PMCID: PMC5654318          DOI: 10.1016/j.freeradbiomed.2016.06.021

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  62 in total

Review 1.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 2.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

3.  Bimodal actions of reactive oxygen species in the differentiation and bone-resorbing functions of osteoclasts.

Authors:  Hyunsoo Kim; Ick Young Kim; Soo Young Lee; Daewon Jeong
Journal:  FEBS Lett       Date:  2006-09-18       Impact factor: 4.124

4.  Bropirimine inhibits osteoclast differentiation through production of interferon-β.

Authors:  Hiroaki Suzuki; Ayako Mochizuki; Kentaro Yoshimura; Yoichi Miyamoto; Kotaro Kaneko; Tomio Inoue; Daichi Chikazu; Masamichi Takami; Ryutaro Kamijo
Journal:  Biochem Biophys Res Commun       Date:  2015-09-21       Impact factor: 3.575

Review 5.  The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy.

Authors:  Taeko Ishii; Yutaka Shimazu; Issei Nishiyama; Junichi Kikuta; Masaru Ishii
Journal:  Mol Cells       Date:  2011-02-25       Impact factor: 5.034

6.  Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.

Authors:  R J van't Hof; S H Ralston
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

7.  Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta.

Authors:  Hyunil Ha; Jong-Ho Lee; Ha-Neui Kim; Han Bok Kwak; Hyun-Man Kim; Shee Eun Lee; Joon Haeng Rhee; Hong-Hee Kim; Zang Hee Lee
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

Review 8.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

9.  Nitric oxide enhances osteoclastogenesis possibly by mediating cell fusion.

Authors:  Dorrin Nilforoushan; Azza Gramoun; Michael Glogauer; Morris F Manolson
Journal:  Nitric Oxide       Date:  2009-04-21       Impact factor: 4.427

10.  TLR signalling augments macrophage bactericidal activity through mitochondrial ROS.

Authors:  A Phillip West; Igor E Brodsky; Christoph Rahner; Dong Kyun Woo; Hediye Erdjument-Bromage; Paul Tempst; Matthew C Walsh; Yongwon Choi; Gerald S Shadel; Sankar Ghosh
Journal:  Nature       Date:  2011-04-28       Impact factor: 49.962

View more
  9 in total

1.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

2.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 3.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

Review 4.  Applications of Titanium Dioxide Nanostructure in Stomatology.

Authors:  Shuang Liu; Xingzhu Chen; Mingyue Yu; Jianing Li; Jinyao Liu; Zunxuan Xie; Fengxiang Gao; Yuyan Liu
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

5.  Proinflammatory M1 Macrophages Inhibit RANKL-Induced Osteoclastogenesis.

Authors:  Tsuguno Yamaguchi; Alexandru Movila; Shinsuke Kataoka; Wichaya Wisitrasameewong; Montserrat Ruiz Torruella; Michiaki Murakoshi; Shinya Murakami; Toshihisa Kawai
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 6.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  Osteoclastogenesis Behavior of Zirconia for Dental Implant.

Authors:  Boldbayar Ganbold; Seong-Kyun Kim; Seong-Joo Heo; Jai-Young Koak; Zang Hee Lee; Jaejin Cho
Journal:  Materials (Basel)       Date:  2019-03-04       Impact factor: 3.623

8.  Early urinary protein changes during tumor formation in a NuTu-19 tail vein injection rat model.

Authors:  Jing Wei; Na Ni; Wenshu Meng; Yuhang Huan; Youhe Gao
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

9.  Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.

Authors:  Wenli Jiang; Youlutuziayi Rixiati; Hao Huang; YiJun Shi; Caiguo Huang; Binghua Jiao
Journal:  Cancer Med       Date:  2020-09-25       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.